While elevated levels of galectin-9 were also found in patients with IgAN and DKD, serum galectin-9 demonstrated a higher AUC of 0.766 for distinguishing PMN patients from non-PMN individuals (sensitivity = 81.2%, specificity = 65%, Figure 7F). This evidence concerns the gene LGALS9 and diabetic kidney disease.